June 6, 2008 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Zaleplon Capsules, CIV. This product is AB rated and bioequivalent to Sonata®* Capsules. Zaleplon Capsules are available in 5 mg and 10 mg strengths, in bottle sizes of 100.
“Our customers count on Teva for a continuous supply of new generic products,” states John Denman, V.P. Sales and Marketing. “With the launch of Zaleplon Capsules we add another quality product to our broad line of affordable generic pharmaceuticals.”